ATYR vs MKC · rev $190.0K vs P/E 8.4, rev $3.81B
aTyr Pharma, Inc. (ATYR) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
ATYR currently screens at market cap $471.7M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the ATYR and MKC stock pages for the full models.
Not investment advice.